Product Description |
Host |
Target Species |
Applications |
Size |
Product # |
V A - ß - M S H , L i p o t r o p i n - ? , P r o o p i o m e l a n o c o r t i n d e r i v e d |
|
|
|
1mg |
5-02068 |
V5 Epitope Tag |
|
|
|
5mg |
5-02067 |
VA MSH beta - |
N/A |
Hu |
N/A |
100 ug |
043-42 |
Val-Asp-(Arg8)-Vasopressin |
|
|
|
1mg |
5-02069 |
Val-Ile-His-Ser - |
N/A |
N/A |
N/A |
1 mg |
070-84 |
Valorphin |
|
|
|
5mg |
5-02070 |
Valosin Peptide (VQY), porcine |
|
|
|
1mg |
5-02071 |
Vanilloid Receptor Subtype 1 (VR1) |
|
|
|
1 mg |
5-43221 |
Vanilloid Receptor Subtype 1 (VR1) |
|
|
|
2 mg |
5-43222 |
Vanilloid Receptor Subtype 1 (VR1) |
|
|
|
5 mg |
5-43223 |
Vanilloid Receptor Subtype 1 (VR1) |
|
|
|
1mg |
5-02072 |
VAP-33 N-terminal Fragment - |
N/A |
N/A |
N/A |
200 ug |
058-74 |
VAP-33 N-terminal from upstream ATG - |
N/A |
N/A |
N/A |
200 ug |
058-73 |
VASH 1 Protein (174-204) Isoform 2 (28aa) - |
N/A |
Hu |
N/A |
100 ug |
002-95 |
Vasoactive Intestinal Constractor [VIC]; Endophilin Beta, Mouse |
|
|
|
1mg |
5-02075 |
Vasoactive Intestinal Contractor [VIC] |
|
|
|
1mg |
5-02073 |
Vasoactive Intestinal Octacosapeptide - |
N/A |
Ca |
N/A |
200 ug |
064-13 |
Vasoactive Intestinal peptide |
|
|
|
0.5 mg |
5-43233 |
Vasoactive Intestinal peptide |
|
|
|
1 mg |
5-43234 |
Vasoactive Intestinal peptide |
|
|
|
2.5 mg |
5-43235 |
Vasoactive Intestinal peptide |
|
|
|
1mg |
5-02074 |
Vasoactive Intestinal Peptide (VIP) (4-28) - |
N/A |
Hu, Ms, Rt |
N/A |
200 ug |
064-30 |
Vasoactive Intestinal Peptide (VIP) Antagonist - |
N/A |
N/A |
N/A |
200 ug |
064-21 |
Vasoactive Intestinal Peptide (VIP) Receptor Antagonist - |
N/A |
N/A |
N/A |
200 ug |
064-22 |
Vasoactive Intestinal Peptide (VIP) Receptor Binding Inhibitor (L-8-K) - |
N/A |
N/A |
N/A |
200 ug |
064-23 |
Vasoactive Intestinal Peptide (VIP)( Ovine) - |
N/A |
Hu, Ms, Po, Rt, Ov |
N/A |
200 ug |
064-16 |
Vasoactive Intestinal Peptide (VIP)(1-12) - |
N/A |
Hu, Po, Rt |
N/A |
1 mg |
064-18 |
Vasoactive Intestinal Peptide (VIP)(10-28) - VIP Antagonist - |
N/A |
Hu, Po, Rt |
N/A |
200 ug |
064-19 |
Vasoactive Intestinal Peptide (VIP)(81-122) - (PHV-42) - |
N/A |
Hu |
N/A |
200 ug |
064-09 |
Vasoactive Intestinal Peptide (VIP)(GP) - |
N/A |
N/A |
N/A |
200 ug |
064-14 |
Vasoactive Intestinal Peptide (VIP)(PHM)(111-122) - (PHM-VIP Space Peptide) - |
N/A |
N/A |
N/A |
500 ug |
064-10 |
Vasoactive Intestinal Peptide (VIP1) Agonist Secretin [Arg16] - |
N/A |
Ca |
N/A |
200 ug |
064-27 |
Vasoactive Intestinal Peptide (VIP1) Agonist: [Lys15 - Arg16 - Leu27]-VIP (1-7)-GRF (8-27) - |
N/A |
N/A |
N/A |
200 ug |
064-24 |
Vasoactive Intestinal Peptide (VIP1) Receptor 1 Antagonist: [Ac-His1 - D-Phe2 - Lys15 - Arg16 - Leu27]-VIP (1-7)-GRF (8-27) - |
N/A |
N/A |
N/A |
200 ug |
064-25 |
Vasohibin (286-299) - |
N/A |
Hu |
N/A |
100 ug |
002-96 |
Vasohibin [Cys0]-(336-365) - |
N/A |
Hu |
N/A |
100 ug |
002-94 |
Vasonatrin Peptide (VNP) |
|
|
|
1mg |
5-02076 |
Vasonatrin Peptide (VNP) - |
N/A |
N/A |
N/A |
200 ug |
005-47 |
Vasopressin (151-165) |
N/A |
N/A |
N/A |
200 ug |
065-36 |
Vasopressin (151-168) |
N/A |
N/A |
N/A |
200 ug |
065-35 |
Vasopressin (AVP) Desamino-[Arg8]( Ovine) - |
N/A |
Hu, Ms, Rt, Ov |
N/A |
1 mg |
065-10 |
Vasopressin (AVP) Desamino-[D-Arg8](DDAVP)( Ovine) - |
N/A |
Hu, Ms, Rt, Ov |
N/A |
500 ug |
065-11 |
Vasopressin (AVP) Desglycinamide-Desamino-[Arg8]( Ovine) - |
N/A |
Hu, Ms, Rt, Ov |
N/A |
1 mg |
065-13 |
Vasopressin (AVP) Desglycinamide-Desamino-[Lys8]( Ovine) - |
N/A |
Hu, Ms, Rt, Ov |
N/A |
1 mg |
065-29 |
Vasopressin (AVP) Desglycinamide-[Arg8]( Ovine) - |
N/A |
Hu, Ms, Rt, Ov |
N/A |
1 mg |
065-12 |
Vasopressin (AVP) Desglycinamide-[d(CH2)5 -D-Ile2 -Ile4 -Arg8]( Ovine) - |
N/A |
Hu, Ms, Rt, Ov |
N/A |
1 mg |
065-18 |
Vasopressin (AVP) Desglycinamide-[Lys8]( Ovine) - |
N/A |
Hu, Ms, Rt, Ov |
N/A |
1 mg |
065-28 |
Vasopressin (AVP)(4-8)[pGlu4 -Cys6](Vasopressin Metabolite Neuropeptide)( Ovine) - |
N/A |
Hu, Ms, Rt, Ov |
N/A |
500 ug |
065-25 |
Vasopressin (AVP)(4-9)[pGlu4 -Cys6]( Ovine) - |
N/A |
Hu, Ms, Rt, Ov |
N/A |
500 ug |
065-26 |
Vasopressin (AVP)[1-(Beta-Mercapto-Beta - Beta- Cyclopenta-methylene Propionic Acid) - 2-(O-Methyl)Tyrosine]-Arg8 ( Ovine) - |
N/A |
Hu, Ms, Rt, Ov |
N/A |
1 mg |
065-23 |
Vasopressin (AVP)[1-Adamantaneacetyl1 -D-Tyr(Et)2 - Val4 -Abu6]-Arg8 ( Ovine) - |
N/A |
Hu, Ms, Rt, Ov |
N/A |
1 mg |
065-21 |
Vasopressin (AVP)[1-Adamantaneacetyl1 -D-Tyr(Et)2 -Val4 - Abu6 -Arg9]-Arg8 ( Ovine) - |
N/A |
Hu, Ms, Rt, Ov |
N/A |
1 mg |
065-22 |
Vasopressin (AVP)[Arg8]( Ovine) - |
N/A |
Hu, Ms, Rt, Ov |
N/A |
1 mg |
065-07 |
Vasopressin (AVP)[d(CH2)5 -D-Ile2 -Ile4]-Arg8 ( Ovine) - |
N/A |
Hu, Ms, Rt, Ov |
N/A |
1 mg |
065-17 |
Vasopressin (AVP)[d(CH2)5 -D-Phe2 -Ile4 -Ala9-Amide]-Arg8 ( Ovine) - |
N/A |
Hu, Ms, Rt, Ov |
N/A |
1 mg |
065-20 |
Vasopressin (AVP)[d(CH2)5 -D-Tyr(Et)2 -Val4 -Cit8]( Ovine) - |
N/A |
Hu, Ms, Rt, Ov |
N/A |
1 mg |
065-06 |
Vasopressin (AVP)[d(CH2)5 -Tyr(Et)2 -Val4 -Arg8]( Ovine) - |
N/A |
Hu, Ms, Rt, Ov |
N/A |
1 mg |
065-16 |
Vasopressin (AVP)[D-Arg8]( Ovine) - |
N/A |
Hu, Ms, Rt, Ov |
N/A |
1 mg |
065-09 |
Vasopressin (AVP)[Lys8]( Ovine) - |
N/A |
Hu, Ms, Rt, Ov |
N/A |
1 mg |
065-27 |
Vasopressin (AVP)[Mpr1 -Val4 -D-Arg8]( Ovine) - |
N/A |
Hu, Ms, Rt, Ov |
N/A |
500 ug |
065-15 |
Vasopressin (AVP)[Phe2 -Ile3 -Orn8](Vasotocin [Phe2 -Orn8])( Ovine) - |
N/A |
Hu, Ms, Rt, Ov |
N/A |
1 mg |
065-30 |
Vasopressin (AVP)[Propionyl1 -D-Tyr(Et)2 -Val4 -Abu6 -Arg9]-Arg8 ( Ovine) - |
N/A |
Hu, Ms, Rt, Ov |
N/A |
1 mg |
065-24 |
Vasopressin neurophysin (130-143) |
N/A |
Ms |
N/A |
100 ug |
065-38 |
Vasopressin neurophysin (130-143) |
N/A |
Ms |
N/A |
100 ug |
065-39 |
Vasopressin neurophysin (153-166) |
N/A |
Ms |
N/A |
100 ug |
065-37 |
Vasopressin [Arg8] |
N/A |
N/A |
N/A |
0.5 mg |
4085-v |
Vasopressin [Asu1, 6, Arg8] |
N/A |
N/A |
N/A |
0.5 mg |
4026-v |
Vasopressin [Pmp1, Tyr(Me)2]Arg8 |
N/A |
N/A |
N/A |
0.5 mg |
4203-v |
Vasostatin I (17-43) - |
N/A |
Hu |
N/A |
100 ug |
053-34 |
Vasostatin I (17-76) - |
N/A |
Hu |
N/A |
100 ug |
053-35 |
Vasostatin I [ Chromogranin A (19-94)] - |
N/A |
Hu |
N/A |
100 ug |
053-33 |
Vasostatin II C-terminal [ Chromogranin A (97-131)] - |
N/A |
Hu |
N/A |
100 ug |
053-32 |
Vasotocin [Arg8] |
N/A |
N/A |
N/A |
0.5 mg |
4192-v |
Vasotocin [Arg8] - |
N/A |
N/A |
N/A |
500 ug |
065-31 |
Vasotocin [Asu1 -6 -Arg8] - |
N/A |
N/A |
N/A |
500 ug |
065-33 |
Vasotocin [Asu1, 6, Arg8] |
N/A |
N/A |
N/A |
0.5 mg |
4027-v |
Vasotocin [d(CH2)5 -Tyr(Me)2 -Orn8] - |
N/A |
N/A |
N/A |
1 mg |
051-07 |
Vasotocin [d(CH2)5 -Tyr(Me)2 -Thr4 -Orn8 -Tyr-Amide9](Compound VI)(OVT) - |
N/A |
N/A |
N/A |
200 ug |
051-08 |
Vaspin (257-300) |
N/A |
N/A |
N/A |
100 ug |
002-68 |
Vaspin (386-414) - |
N/A |
N/A |
N/A |
100 ug |
002-66 |
Vaspin (63-104) - |
N/A |
N/A |
N/A |
100 ug |
002-67 |
Vesicular Acetycholine (VAChT)( MK) - |
N/A |
Hu, Ms, Rt |
N/A |
100 ug |
V007 |
Vesicular Stomatitis Virus peptide |
|
|
|
1 mg |
5-43236 |
Vesicular Stomatitis Virus peptide |
|
|
|
2 mg |
5-43237 |
Vesicular Stomatitis Virus peptide |
|
|
|
5 mg |
5-43238 |
Vesicular Stomatitis Virus peptide |
|
|
|
5mg |
5-02077 |
VGF (177-206) |
N/A |
Hu |
N/A |
100 ug |
007-67 |
VGF (177-206) [pGlu1]-- |
N/A |
Hu |
N/A |
100 ug |
007-68 |
VGF (23-59) |
N/A |
Hu, Rt |
N/A |
100 ug |
007-66 |
VGF (23-62) |
N/A |
Hu, Rt |
N/A |
100 ug |
007-65 |
VGF (485-503) |
N/A |
Hu, Rt |
N/A |
100 ug |
007-71 |
VGF (586-615) |
N/A |
Hu, Rt |
N/A |
100 ug |
007-70 |
VIC |
N/A |
Ms |
N/A |
0.1 mg |
4211-s |
VIP |
N/A |
Hu, Po |
N/A |
25 mg |
4110 |
VIP (1 - 12), human, porcine, rat |
|
|
|
5mg |
5-02082 |
VIP (10-28) (human, bovine, porcine, rat) |
|
|
|
1mg |
5-02083 |
VIP (6-28) (human, bovine, porcine, rat) |
|
|
|
1mg |
5-02084 |
VIP / PHM (156-170) |
N/A |
N/A |
N/A |
200 ug |
064-11 |
VIP Receptor-Binding Inhibitor L-8-K |
|
|
|
5mg |
5-02081 |
VIP, Antagonist |
|
|
|
1mg |
5-02078 |